Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech companies ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.8). Figures as of 18 Nov 2026, 19:59 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.3
Combined market value
SAR 3.14T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
SAR
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7SAR 138.8BSAR 938.91 0.19% down 49% up United States
2QiagenQGEN · Health Care4.9SAR 38.4BSAR 185.99 0.33% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.8SAR 62.2BSAR 614.47 1.27% down 20% up United States
4BioNTechBNTX · Health Care6.5SAR 77.7BSAR 313.38 1.55% down 16% down Germany
5AmgenAMGN · Health Care6.5SAR 900.3BSAR 1,664.47 3.10% down 34% up United States
6Gilead SciencesGILD · Health Care7.1SAR 787.2BSAR 634.63 0.63% down 33% up United States
7ExelixisEXEL · Health Care7.2SAR 62.9BSAR 257.75 0.31% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9SAR 41.2BSAR 361.33 0.38% up 37% up United States
9Bio-TechneTECH · Health Care9.4SAR 42.9BSAR 273.00 0.21% up 26% up United States
10argenxARGX · Health Care14.3SAR 222.6BSAR 3,538.99 0.43% down 4% up Belgium
11RepligenRGEN · Health Care14.9SAR 41.2BSAR 644.68 5.97% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.6SAR 17.3BSAR 106.83 0.04% down 88% up United States
13Twist BioscienceTWST · Health Care21.1SAR 29.8BSAR 437.05 4.03% up 340% up United States
14Krystal BiotechKRYS · Health Care23.9SAR 34.9BSAR 1,177.23 5.12% up 46% up United States
15ModernaMRNA · Health Care41.4SAR 301.6BSAR 745.28 3.92% down 755% up United States
16ImmunityBioIBRX · Health Care63.3SAR 26.9BSAR 25.28 7.67% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care264SAR 38.9BSAR 455.22 0.13% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1125SAR 14.8BSAR 152.74 1.42% up 21% down Switzerland
19CG OncologyCGON · Health Care1769SAR 26.8BSAR 300.14 1.36% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.8) have the lowest P/S ratio of the 19 biotech companies ranked here as of 18 Nov 2026, 19:59 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of SAR 3.14T as of 18 Nov 2026, 19:59 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.